Ventana Medical Systems, Inc.

Other

Roche Molecular Systems, Inc.

Htg Molecular Diagnostics, Inc.

Spring Bioscience Corporation

Roche Diagnostics Gmbh

F. Hoffmann-la Roche Ag

Patrick C Roche

Hartmut Koeppen

Yifei Zhu

Zhiming Liao

Marcin Kowanetz

Bharathi Vennapusa

Zachary Boyd

Michael Schraeml

Greg Martin

Birgit Bossenmaier

Michael Gerg

Sebastian Dziadek

Fabien Gaire

Monika Soukupova

Bonnie LaFleur

James Grille

Linda Willoughby Kivi

John W Luecke

Patricia Carrigan

Mark Robida

William C Powell

Qian Liu

Jeff Verhasselt

Gary Gooch

The invention provides programmed death-ligand 1 (PD-L1) antibodies and methods of using the same.

Anti-PD-L1 antibodies and diagnostic uses thereof

Described herein are innovations for classifying subtypes of DLBCL, as well as using the results of classification for diagnosis, prognosis, and therapy selection. In this way, the classifier can effectively classify subtypes of DLBCL and provide meaningful output for the benefit of medical practices and DLBCL patients. Also described are arrays and kits that can be used to measure expression of DLBCL signatures genes.

Methods for subtyping diffuse large B-cell lymphoma (DLBCL)

A modular attic walkway system for creating a walkway across attic joists which includes a plurality of attic joists each has a top face. A plurality of platforms is removably attached to the top faces such that each platform traverses between adjacent attic joists. Each of the platforms is releasably interlocked with an adjacent one of the platforms. Each platform includes a panel. The panel has a top surface, a bottom surface, and a perimeter surface which extends between the top and bottom surfaces. The perimeter surface includes a first mating edge, a second mating edge, a first lateral edge, and a second lateral edge. The first mating edge includes a tongue cutout which extends inwardly from the first mating edge toward the second mating edge. A tongue extension extends outwardly away from the second mating edge and releasably interlocks with a tongue cutout of an adjacently positioned panel.

Modular attic walkway system

The present invention relates to isolated antibodies, or an antigen portions thereof, which bind to human HER3. The novel antibodies are of great utility since they allow for the sensitive and specific detection of human HER3. Detection of human HER3 is, e.g., possible in a tissue sample, even when such tissue sample is a formalin-fixed paraffin embedded tissue (FFPET) sample.

Antibodies specifically binding to HER3

Methods, kits, and systems for clarifying obfuscating pigments in histology samples such as an automated method of treating a histology sample with a clarifying reagent so that the clarifying reagent, contacts the sample and the pigments within the sample are decolorized , thus alleviating staining obfuscations associated with pigments. Decolorizing the pigments within the sample enables the histology sample to be interpretable by a qualified reader. An antigen retrieval step is performed after the clarification step.

Automated methods, kits, and systems for clarifying obfuscating pigments in histology samples

Disclosed herein are antigen-binding molecules, such as antibodies, that specifically recognize a portion of the EGFR C-terminal (intracellular) regulatory domain that interacts with one or more regulatory molecules (such as Suppressor of Cytokine Signaling ('SOCS') proteins). In certain normal or neoplastic cells and/or tissues, this region is inaccessible to the disclosed antigen-binding molecules. Thus, such antigen-binding molecules are useful at least to interrogate the regulated state of EGFR, predict the response of a cancer patient to EGFR inhibitor therapies, and/or predict the aggressiveness of neoplasms.

Methods of predicting response of a neoplasm to an EGFR inhibitor and detecting interactions between EGFR and an EGFR regulatory protein

A test assembly for water-flow alarms having a housing made up of two sections. One section includes a control valve, and the other section a viewing chamber. The control valve is capable of a passing water therethrough at two distinct flow rates, one of which being equivalent to the flow rate passing through the orifice of a sprinkler. The viewing chamber contains a uniquely designed sight module therein through which the flow of water can be viewed. By incorporating the test assembly within a sprinkler system it is possible to reliably test a water-flow alarm without activating the sprinkler within the system.

Test assembly for water-flow alarms

Growing community of inventors

Tucson, AZ, United States of America

Patrick C Roche